Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.


Increasing incidences of obesity and diabetes have made diabetic kidney disease (DKD) the leading cause of chronic kidney disease and end-stage renal disease worldwide. Despite current pharmacological treatments, including strategies for optimizing glycemic control and inhibitors of the renin-angiotensin system, DKD still makes up almost one-half of all… (More)
DOI: 10.1152/ajprenal.00314.2016